Drug intelligence / Profile preview

human relaxin-1

Development stage
Preclinical
Lead developer
Relaxera
Modality
Peptides
Administration
Intravenous, Subcutaneous
01

Overview

Human relaxin-1 is a synthetic peptide developed by Relaxera that mimics the endogenous human H1 relaxin hormone. It functions as a dual agonist of the relaxin-family peptide receptors RXFP1 and RXFP2. While human relaxin-2 (H2) is the most studied member of the family and the primary circulating form in humans, relaxin-1 is known to be expressed in specific tissues such as the decidua, trophoblast, and prostate, suggesting localized physiological roles. Relaxera's synthetic version is utilized in preclinical research to explore therapeutic potential in areas such as fibrosis, cardiovascular disease, and reproductive health, leveraging the peptide's ability to modulate extracellular matrix metabolism, promote vasodilation, and exert anti-inflammatory effects.

Other names
H1 relaxinH-1 relaxinH 1 relaxinRelaxin-1Relaxin1Relaxin 1
02

Targets

RXFP2 (Relaxin family peptide receptor 2)RXFP1 (Relaxin family peptide receptor 1)

Beyond the preview

Go deeper on human relaxin-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human relaxin-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call